RxDoctor Payments Data

Michael Khazzam, MD

Orthopaedic Surgery · Grapevine, TXNPI 1093821902

Payments from drug & device makers

$297,360in general payments, 2019–2025

Across 141 payments — averaging $2108.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$294K
  • Tigon Medical LLC$3K
  • Arthrex$140
  • Change Healthcare Technologies, LLC$127
  • Johnson & Johnson$113
  • Encore Medical, LP$72
  • plus $165 from 7 others
$1,575in research payments, 2019–2025

Across 4 payments — averaging $393.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Stryker$2K

What the payments were for

  • Royalty or licence$216,55376%
  • Consulting fees$51,82518%
  • Speaking & faculty fees$6,7682%
  • Travel & lodging$6,0592%
  • Food & beverage$2,1921%
  • Gifts$6440%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$297,360 in reported general payments places this provider in the 95th percentile of 1,337 orthopaedic surgery providers in Texas.

See all orthopaedic surgery providers in Texas

Medicare billing

Part B allowed, 2024
$275,108
Medicare patients
501
Services billed
1,300

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Etodolac176$4,665
Oxycodone Hcl243$1,497
Celecoxib108$1,414
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen57$1,013
Ondansetron Hcl67$720
Methocarbamol32$354
Tramadol Hcl88$336
Mupirocin14$107
Amoxicillin47$95
Clindamycin Hcl17$20

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Grapevine

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →